Macrophage scores Series A funds
Macrophage Pharma Limited, a newly formed immune-oncology company, has secured 9 million pounds in Series A funding. CRT Pioneer Fund led the round with participation from Novo Seeds and Aglaia Biomedical Ventures.
9 January 2017•1 min read
